Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study-Reference-Cited by-同舟云学术

Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study

Published:2016-02 Issue:2 Volume:48 Page:154-161
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Esteve Maria,Temiño Rocío,Carrasco Anna,Batista Lissette,Del Val Adolfo,Blé Michel,Santaolaria Santos,Molina-Infante Javier,Soriano Germán,Agudo Sandra,Zabana Yamile,Andújar Xavier,Aceituno Montserrat,Ribes Josepa,Madridejos Rosa,Fernández-Bañares Fernando

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Severe sprue-like enteropathy associated with olmesartan;Rubio-Tapia;Mayo Clinic Proceedings,2012

2. Olmesartan-associated enteropathy: results of a national survey;Marthey;Alimentary Pharmacology and Therapeutics,2014

3. Systematic review: sprue-like enteropathy associated with olmesartan;Ianiro;Alimentary Pharmacology and Therapeutics,2014

4. Editorial: sprue-like enteropathy due to olmesartan and other angiotensin receptor blockers – the plot thickens;Lebwohl;Alimentary Pharmacology and Therapeutics,2014

5. Olmesartan and intestinal adverse effects in the ROADMAP study;Menne;Mayo Clinic Proceedings,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers;Alimentary Pharmacology & Therapeutics;2024-01-07

2. Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report;Acta Gastro Enterologica Belgica;2023-03

3. Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report;ACTA GASTRO-ENT BELG;2023

4. Olmesartan-associated Enteropathy with Acute Kidney Injury;The Korean Journal of Gastroenterology;2022-03-25

5. Evaluation of anti-inflammatory, immunomodulatory effects and celiac-like side effect of olmesartan medoxomil as a vitamin D receptor agonist and angiotensin II receptor blocker;Journal of Research in Pharmacy;2022